Detection of EpCAM-negative and cytokeratin-negative circulating tumor cells in peripheral blood

Journal of Oncology

Volumn , Issue , 2011, Pages

  Mikolajczyk, Stephen D ^a   Millar, Lisa S ^a   Tsinberg, Pavel ^a   Coutts, Stephen M ^a   Zomorrodi, Maryam ^a   Pham, Tam ^a   Bischoff, Farideh Z ^a   Pircher, Tony J ^a  

^a Biocept Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; CYTOKERATIN ANTIBODY; EPITHELIAL CELL ADHESION MOLECULE; EPITHELIAL CELL ADHESION MOLECULE ANTIBODY; FLUORESCENT DYE; MEMBRANE ANTIGEN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CELL LABELING; CELL STRAIN LNCAP; CIRCULATING TUMOR CELL; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG SMALL CELL CANCER; MALE; MICROFLUIDIC ANALYSIS; PROSTATE CANCER; PROTEIN EXPRESSION;

EID: 79959263061     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/252361     Document Type: Article

References (37)

1. Fehm T., Solomayer E. F., Meng S., Tucker T., Lane N., Wang J., Gebauer G., Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells Cytotherapy 2005 7 2 171 185 (Pubitemid 40872753)
2. Paterlini-Brechot P., Benali N. L., Circulating tumor cells (CTC) detection: clinical impact and future directions Cancer Letters 2007 253 2 180 204 (Pubitemid 47017533)
3. Allard W. J., Matera J., Miller M. C., Repollet M., Connelly M. C., Rao C., Tibbe A. G. J., Uhr J. W., Terstappen L. W. M. M., Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases Clinical Cancer Research 2004 10 20 6897 6904 (Pubitemid 39383039)
4. Riethdorf S., Fritsche H., Muller V., Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the cellSearch system Clinical Cancer Research 2007 13 920 928 (Pubitemid 46340368)
5. Allan A. L., Keeney M., Circulating tumor cell analysis: technical and statistical considerations for application to the clinic International Journal of Oncology 2010 2010 1 11
6. Nagrath S., Sequist L. V., Maheswaran S., Bell D. W., Irimia D., Ulkus L., Smith M. R., Kwak E. L., Digumarthy S., Muzikansky A., Ryan P., Balis U. J., Tompkins R. G., Haber D. A., Toner M., Isolation of rare circulating tumour cells in cancer patients by microchip technology Nature 2007 450 7173 1235 1239
7. Fehm T., Hoffmann O., Aktas B., Becker S., Solomayer E. F., Wallwiener D., Kimmig R., Kasimir-Bauer S., Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells Breast Cancer Research 2009 11 4 R59
8. Hofman V., Bonnetaud C., Ilie M. I., Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker Clinical Cancer Research 2011 17 827
9. Marrinucci D., Bethel K., Lazar D., Cytomorphology of circulating colorectal tumor cells: a small case series Journal of Oncology 2010 2010
10. Camara O., Jrke C., Hammer U., Monitoring circulating epithelial tumour cells (CETC) to gauge therapy: in patients with disease progression after trastuzumab persisting CETC can be eliminated by combined lapatinib treatment Journal of Cancer Research and Clinical Oncology 2008 135 643 647
11. Fehm T., Becker S., Duerr-Stoerzer S., Sotlar K., Mueller V., Wallwiener D., Lane N., Solomayer E., Uhr J., Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status Breast Cancer Research 2007 9 5 R74
12. Helo P., Cronin A. M., Danila D. C., Wenske S., Gonzalez-Espinoza R., Anand A., Koscuiszka M., Vnnen R. M., Pettersson K., Chun F. K. H., Steuber T., Huland H., Guillonneau B. D., Eastham J. A., Scardino P. T., Fleisher M., Scher H. I., Lilja H., Circulating prostate tumor cells detected by Reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival Clinical Chemistry 2009 55 4 765 773
13. Moll R., Divo M., Langbein L., The human keratins: biology and pathology Histochemistry and Cell Biology 2008 129 6 705 733
14. Pachmann K., Camara O., Kohlhase A., Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy Journal of Cancer Research and Clinical Oncology 2010 137 5 821 828
15. Shaffer D. R., Leversha M. A., Danila D. C., Lin O., Gonzalez-Espinoza R., Gu B., Anand A., Smith K., Maslak P., Doyle G. V., Terstappen L. W. M. M., Lilja H., Heller G., Fleisher M., Scher H. I., Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer Clinical Cancer Research 2007 13 7 2023 2029 (Pubitemid 46649868)
16. Schrder C. P., Ruiters M. H. J., De Jong S., Tiebosch A. T. M. G., Wesseling J., Veenstra R., De Vries J., Hoekstra H. J., De Leij L. F. M. H., De Vries E. G. E., Detection of micrometastatic breast cancer by means of real time quantitative RT-PCR and immunostaining in perioperative blood samples and sentinel nodes International Journal of Cancer 2003 106 4 611 618 (Pubitemid 36966222)
17. De Bono J. S., Scher H. I., Montgomery R. B., Parker C., Miller M. C., Tissing H., Doyle G. V., Terstappen L. W. W. M., Pienta K. J., Raghavan D., Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer Clinical Cancer Research 2008 14 19 6302 6309
18. Scher H. I., Jia X., de Bono J. S., Fleisher M., Pienta K. J., Raghavan D., Heller G., Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data The Lancet Oncology 2009 10 3 233 239
19. Attard G., Swennenhuis J. F., Olmos D., Reid A. H. M., Vickers E., A'Hern R., Levink R., Coumans F., Moreira J., Riisnaes R., Oommen N. B., Hawche G., Jameson C., Thompson E., Sipkema R., Carden C. P., Parker C., Dearnaley D., Kaye S. B., Cooper C. S., Molina A., Cox M. E., Terstappen L. W. M. M., De Bono J. S., Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer Cancer Research 2009 69 7 2912 2918
20. Lilja H., Scher H. I., Detection of androgen receptor mutations in circulating tumor cells: highlights of the long road to clinical qualification Clinical Chemistry 2010 56 1375 1377
21. Leversha M. A., Han J., Asgari Z., Danila D. C., Lin O., Gonzalez-Espinoza R., Anand A., Lilja H., Heller G., Fleisher M., Scher H. I., Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer Clinical Cancer Research 2009 15 6 2091 2097
22. Pestrin M., Bessi S., Galardi F., Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients Breast Cancer Research and Treatment 2009 118 523 530
23. Went P. T., Lugli A., Meier S., Bundi M., Mirlacher M., Sauter G., Dirnhofer S., Frequent EpCam protein expression in human carcinomas Human Pathology 2004 35 1 122 128 (Pubitemid 38133932)
24. Spizzo G., Went P., Dirnhofer S., Obrist P., Simon R., Spichtin H., Maurer R., Metzger U., Von Castelberg B., Bart R., Stopatschinskaya S., Kchli O. R., Haas P., Mross F., Zuber M., Dietrich H., Bischoff S., Mirlacher M., Sauter G., Gastl G., High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer Breast Cancer Research and Treatment 2004 86 3 207 213 (Pubitemid 39070963)
25. Tai K. Y., Shiah S. G., Shieh Y. S., Kao Y. R., Chi C. Y., Huang E., Lee H. S., Chang L. C., Yang P. C., Wu C. W., DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression Oncogene 2007 26 27 3989 3997 (Pubitemid 46884302)
26. Alix-Panabires C., Vendrell J. P., Slijper M., Pell O., Barbotte E., Mercier G., Jacot W., Fabbro M., Pantel K., Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer Breast Cancer Research 2009 11 3 R39
27. Woelfle U., Sauter G., Santjer S., Brakenhoff R., Pantel K., Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer Clinical Cancer Research 2004 10 8 2670 2674 (Pubitemid 38509140)
28. Franzn B., Linder S., Alaiya A. A., Eriksson E., Uruy K., Hirano T., Okuzawa K., Auer G., Analysis of polypeptide expression in benign and malignant human breast lesions; down-regulation of cytokeratins British Journal of Cancer 1996 74 10 1632 1638 (Pubitemid 26386093)
29. Willipinski-Stapelfeldt B., Riethdorf S., Assmann V., Woelfle U., Rau T., Sauter G., Heukeshoven J., Pantel K., Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells Clinical Cancer Research 2005 11 22 8006 8014 (Pubitemid 41698741)
30. Choesmel V., Pierga J. Y., Nos C., Vincent-Salomon A., Sigal-Zafrani B., Thiery J. P., Blin N., Enrichment methods to detect bone marrow micrometastases in breast carcinoma patients: clinical relevance Breast Cancer Research 2004 6 5 R556 R570
31. Kowalewska M., Nowak R., Chechlinska M., Implications of cancer-associated systemic inflammation for biomarker studies Biochimica et Biophysica Acta 2010 1806 163 171
32. van der Gun B. T. F., Wasserkort R., Monami A., Jeltsch A., Rask T., laska-Kiss K., Cortese R., Rots M. G., De Leij L. F. M. H., Ruiters M. H. J., Kiss A., Weinhold E., McLaughlin P. M. J., Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation International Journal of Cancer 2008 123 2 484 489 (Pubitemid 351842037)
33. Thurm H., Ebel S., Kentenich C., Hemsen A., Riethdorf S., Coith C., Wallwiener D., Braun S., Oberhoff C., Jnicke F., Pantel K., Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy Clinical Cancer Research 2003 9 7 2598 2604 (Pubitemid 36842102)
34. Stott S. L., Hsu C. H., Tsukrov D. I., Isolation of circulating tumor cells using a microvortex-generating herringbone-chip Proceedings of the National Academy of Sciences 2010 107 18392 18397
35. Meng S., Tripathy D., Frenkel E. P., Shete S., Naftalis E. Z., Huth J. F., Beitsch P. D., Leitch M., Hoover S., Euhus D., Haley B., Morrison L., Fleming T. P., Herlyn D., Terstappen L. W. M. M., Fehm T., Tucker T. F., Lane N., Wang J., Uhr J. W., Circulating tumor cells in patients with breast cancer dormancy Clinical Cancer Research 2004 10 24 8152 8162 (Pubitemid 40053373)
36. Camara O., Kavallaris A., Nschel H., Rengsberger M., Jrke C., Pachmann K., Seeding of epithelial cells into circulation during surgery for breast cancer: the fate of malignant and benign mobilized cells World Journal of Surgical Oncology 2006 4, article 67
37. Coumans F. A. W., Doggen C. J. M., Attard G., de Bono J. S., Terstappen L. W. M. M., All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer Annals of Oncology 2010 21 1851 1857